Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:JRO

Nuveen Floating Rate Income Opportunity Fund (JRO) Stock Price, News & Analysis

Nuveen Floating Rate Income Opportunity Fund logo

About Nuveen Floating Rate Income Opportunity Fund Stock (NYSE:JRO)

Advanced Chart

Key Stats

Today's Range
$7.82
$7.88
50-Day Range
$7.64
$7.94
52-Week Range
$7.45
$8.98
Volume
156,700 shs
Average Volume
174,186 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuveen Floating Rate Income Opportunity Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Symphony Asset Management LLC. It invests in fixed income markets of the United States. The fund invests in adjustable rate loans, primarily in senior loans. It benchmarks the performance of its portfolio against the Barclays U.S. Aggregate Bond Index and CSFB Leveraged Loan Index. Nuveen Floating Rate Income Opportunity Fund was formed on April 27, 2004 and is domiciled in the United States.

Receive JRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Floating Rate Income Opportunity Fund and its competitors with MarketBeat's FREE daily newsletter.

JRO Stock News Headlines

Nuveen Floating Rate Income C
BNY Mellon Floating Rate Income Y
HOTTEST TRADER IN AMERICA 🔥🔥🔥
Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Biosciences before it skyrocketed 2,269% in less than 24 hours…
Nuveen Floating Rate Income Fund
See More Headlines

JRO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuveen Floating Rate Income Opportunity Fund investors own include Blackstone (BX), CVS Health (CVS), NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Verizon Communications (VZ) and AbbVie (ABBV).

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-11,455,506.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NYSE:JRO) was last updated on 1/10/2025 by MarketBeat.com Staff
From Our Partners